Nov. 30, 2004 — The U.S. Food and Drug Administration (FDA) and King Pharmaceuticals, Inc., have notified healthcare professionals via letter of labeling changes for existing prescribing and route of ...

The preferred antibiotic treatment for syphilis is in short supply across the United States as infections soar, and more than three dozen leading public health groups are urging the White House to ...

Pfizer announced last week that it expects to run out of a key drug for treating syphilis in the near future — a looming problem that health professionals say could exacerbate syphilis rates, widen ...

Bicillin—a common form of penicillin manufactured by Pfizer and used to treat syphilis—is the newest antibiotic to face a shortage, causing the drugmaker to recommend the use of an alternative, less ...

Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during ...

Penicillin G benzathine, penicillin G procaine equal amounts; combined penicillin G dose 600,000 units/mL; susp for deep IM inj; contains parabens. Give by deep IM inj into upper, outer buttock ...

Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during ...